Acadia Pharmaceuticals (DR6.STU) Q2 2026 Earnings

6MayConfirmed
Q2 2026
0.02
0.03
0.03
0.04

Details

Expected EPS
0.042981457
Actual EPS
0.01702
Surprise EPS
-0.03
Surprise Percent
+60.4%

Description

Acadia Pharmaceuticals (DR6.STU) has reported earnings of 0.01702 per share for Q2 2026.

0 Comments

Share your thoughts